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Introduction
Cancer is uncontrolled growth of cells, and occurs 
in any part of the body (Keyghobadi et al., 2015; WHO, 
2015a).It is one the most important health problems in 
the world (Youlden et al., 2014). In 2012, there were 14.1 
million new cases of cancer in the world. It is predicted 
to increase to 22 million new cases per years until two 
next decades. Cancer is an obstacle to progress and 
well-being in the societies (Stewart and Wild, 2014). It 
affects everyone (old and young, poor and rich, and men 
and women), and associated with the great burden on 
the communities and countries. It is also the major cause 
of death in all communities, especially in developing 
countries (WHO, 2015a). Breast cancer includes 1.67 
million new cases per years and 25% of all types of 
cancers, and is the second common cancer (Ferlay et al., 
2015). Despite advances in cancer research, diagnosis and 
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Abstract
 Background: Breast cancer is the most common malignancy in women worldwide and its incidence is generally 
increasing. In 2012, it was the second most common cancer in the world. It is necessary to obtain information on 
incidence and mortality for health planning. This study aimed to investigate the relationship between the human 
development index (HDI), and the incidence and mortality rates of breast cancer in the world in 2012. Materials 
and Methods: This ecologic study concerns incidence rate and standardized mortality rates of the cancer from 
GLOBOCAN in 2012, and HDI and its components extracted from the global bank site. Data were analyzed 
using correlation tests and regression with SPSS software (version 15). Results: Among the six regions of WHO, 
the highest breast cancer incidence rate (67.6) was observed in the PAHO, and the lowest incidence rate was 27.8 
for SEARO. There was a direct, strong, and meaningful correlation between the standardized incidence rate 
and HDI (r=0.725, p≤0.001). Pearson correlation test showed that there was a significant correlation between 
age-specific incidence rate (ASIR) and components of the HDI (life expectancy at birth, mean years of schooling, 
and GNP). On the other, a non-significant relationship was observed between ASIR and HDI overall (r=0.091, 
p=0.241). In total, a significant relationship was not found between age-specific mortality rate (ASMR) and 
components of HDI. Conclusions: Significant positive correlations exist between ASIR and components of the 
HDI. Socioeconomic status is directly related to the stage of the cancer and patient’s survival. With increasing 
the incidence rate of the cancer, mortality rate from the cancer does not necessariloy increase. This may be due to 
more early detection and treatment in developed that developing countries. It is necessary to increase awareness 
of risk factors and early detection in the latter. 
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treatment of breast cancer is a challenge worldwide. The 
global burden of the disease is directly related to aging 
of population and behaviors associated with the cancer, 
so that the number of women suffering from the cancer 
continues to rise (Cecilio et al., 2015). The incidence 
rate of breast canceris different from 27 per 100,000 in 
African and East Asia to 96 per 100,000 in west Europe 
(WHO, 2015b). The cancer is the fifth cause of death, with 
522,000 deaths in 2012 (Ferlay et al., 2015). Many risk 
factors, such as older age, a positive family history, late 
menopause, early menstruation, obesity after menopause, 
late pregnancy, and a history of hormone therapy, are 
related to the cancer (WHO, 2015b).
Studies have been shown that economic and social 
situation is directly related to the stage at diagnosis and 
survival of the patients (Clegg et al., 2009). It is also has 
been found that the incidence of the disease is higher 
in developed countries then developing countries due 
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to increasing life expectancy, urbanization, and higher 
exposure to risk factors (WHO, 2015b). To determine 
progress and human development of the countries, the 
Human Development Index (HDI) is used by the United 
Nations Development Program (UNDP). It is a composite 
index of longevity, knowledge, and standard of living. 
Longevity is measured with life expectancy at birth, 
knowledge with potential years of education, and adequate 
standard of living with income or Gross National Product 
(GDP) per capita. HDI is a number between zero and one. 
According to HDI, countries in the world are divided into 
four categories, as follows: Countries with very high HDI 
(HDI> = 0.9), countries with a high HDI (HDI> = 0.8), 
medium HDI countries (0.8> HDI> 0.5), and countries 
with a low HDI (HDI <= 0.5)([UNDP], 2014). This study 
aimed to investigate the relationship between HDI, and the 
incidence and mortality rates of breast cancer.
Materials and Methods
This study was an ecologic study in the world for 
assessment the correlation between age-specific incidence 
and mortality rate (ASR) with Human Development 
Index (HDI) and its details that include: Life expectancy 
at birth, Mean years of schooling and Gross national 
income (GNI) per capita. Data about the age-specific 
incidence and mortality rate (ASR) for every country for 
year 2012 get from global cancer project that available 
in (http://globocan.iarc.fr/Default.aspx) and Human 
Development Index (HDI) from Human Development 
Report 2013(Malik, 2013) that include information about 
HDI and its details for every country in the word for year 
2012. 
Method of estimate the age-specific Incidence and 
mortality rates in global cancer project by international 
agency for research on cancer 
Age-specific incidence rate estimate
The methods of estimation are country specific and 
the quality of the estimation depends upon the quality 
and on the amount of the information available for each 
country. In theory, there are as many methods as countries, 
and because of the variety and the complexity of these 
methods, an overall quality score for the incidence and 
mortality estimates combined is almost impossible to 
establish. However an alphanumeric scoring system which 
independently describes the availability of incidence 
and mortality data has been established at the country 
level. The combined score is presented together with the 
estimates for each country with an aim of providing a 
broad indication of the robustness of the estimation.
The methods to estimate the sex- and age-specific 
incidence rates of cancer for a specific country fall into 
one of the following broad categories, in priority order:
1- Rates projected to 2012 (38 countries)-2- Most 
recent rates applied to 2012 population (20 countries)-
3-Estimated from national mortality by modelling, using 
incidence mortality ratios derived from recorded data 
in country-specific cancer registries (13 countries)-4- 
Estimated from national mortality estimates by modelling, 
using incidence mortality ratios derived from recorded 
data in local cancer registries in neighboring countries (9 
European countries)-5-Estimated from national mortality 
estimates using modelled survival (32 countries)-6- 
Estimated as the weighted average of the local rates 
(16 countries)-7- One cancer registry covering part of a 
country is used as representative of the country profile (11 
countries)-8-Age/sex specific rates for “all cancers” were 
partitioned using data on relative frequency of different 
cancers (by age and sex) (12 countries)-9- The rates are 
those of neighboring countries or registries in the same 
area (33 countries) (Jemal, 2011; Ferlay et al., 2015).
Age-specific mortality rate estimate 
Depending of the degree of detail and accuracy of the 
national mortality data, six methods have been utilized 
in the following order of priority: 1-Rates projected to 
2012 (69 countries)-2- Most recent rates applied to 2012 
population (26 countries)-3- Estimated as the weighted 
average of regional rates (1 country)-4- Estimated 
from national incidence estimates by modelling, using 
country-specific survival (2 countries)-5-Estimated from 
national incidence estimates using modelled survival (83 
countries)-6-The rates are those of neighboring countries 
or registries in the same area (3 countries) (Jemal, 2013).
Human Development Index (HDI)
Human Development Index (HDI), a composite 
measure of indicators along three dimensions: life 
expectancy, educational attainment and command over 
the resources needed for a decent living. All groups 
and regions have seen notable improvement in all HDI 
components, with faster progress in low and medium 
HDI countries. On this basis, the world is becoming 
less unequal. Nevertheless, national averages hide large 
variations in human experience. Wide disparities remain 
within countries of both the North and the South, and 
income inequality within and between many countries 
has been rising.(Malik, 2013)
Statistical analysis: In this study, we use of correlation 
bivariate method for assessment the correlation between 
age-specific incidence and mortality rate (ASR) with 
Human Development Index (HDI) and its details that 
include: Life expectancy at birth, Mean years of schooling 
and Gross national income (GNI) per capita. Statistical 
significance was assumed if P< 0.05. All reported P-values 
are two-sided. Statistical analyses were performed using 
SPSS (Version 15.0, SPSS Inc).
Results 
The incidence rate
It was estimated1, 671,149new cases of breast 
cancer in the world in 2012. Of the cases, 882.9(per 
100,000) were attributed to less developed countries, 
while 793.7(per 100,000) were attributed to developed 
countries. According to Globocan. it is the most common 
cancer in women world, with the standardized incidence 
rateof43.1per 100,000. It also includes 25.1% of all 
cancers.
Among the six regions of WHO, the highest breast 
cancer incidence rate (67.6) was observed in the PAHO, 
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and the lowest incidence ratewas27.8for SEARO. 
Considering the regions in terms of HDI, the highest 
incidence rate was 78.2in the regions with very high 
development, and the lowest incidence rate was 26.5 in the 
regions with the medium human development. The highest 
incidence rate (111.9) was seen in Belgium, and the lowest 
rate (9) was related to Mongolia and Lesotho in the world. 
The five countries with the highest standardized incidence 
rate (per 100,000) were Belgium (111.9), Denmark (105), 
Bahamas (98), and Netherlands (96), respectively. 
According to the division of the continents, the highest 
incidence rates were 91.6and91.1 for Northern America 
and Western Europe, respectively. However, the lowest 
incidence rates were26.8and27 for Middle Africa and 
Eastern Asia, respectively (Map1). 
The mortality rate
It was estimated521, 907cases of deaths from breast 
cancer in the world in 2012. Breast cancer is the second 
cause of cancer death, with the standardized mortality 
rate (ASMR) of12.9 (per 100,000), after lung cancer in 
the world. Breast cancer with the mortality rate of 12.9 is 
the first cause of death from cancer in women.
Among the six regions of WHO, the highest 
standardized mortality rate (18.6) was observed in 
the EMRO, and the lowestratewas7 for the WPRO. 
Considering the regions in terms of HDI, the highest 
mortality rate was 17in the regions with low development, 
and the lowest rate was9.8in the regions with the medium 
human development. According to the division of the 
continents, the highest rate was 17, and the lowest rate 
was6.9 for Africa and Eastern Asia, respectively (Map2). 
The five countries with the highest standardized 
mortality rate (per 100,000)were Fiji (28.4), Bahamas 
(26.3), Nigeria (25.9), FYO Macedonia (25.6), and 
Pakistan(25.2), respectively (Map2).
HDI
Mortality to incidence ratio (MIR) was 0.31 for 
the cancer in the world. The ratio for the six regions of 
WHO was different from 0.21 in WPRO and PAHO, and 
0.44inEMRO to 0.65 in SEARO (Table 1).The highest and 
lowest MIRs were 0.56and 0.16 for the continents such 
as the Middle Africa and Northern America.
As can see in Table 2, very high HDI countries had 
the highest ASR, equalto78, while low HDI countries had 
lowest ASR (32.6). Against, very high HDI countries had 
lower mortality rate (14.1) than low HDI countries (17). 
The lowest incidence and mortality was seen in countries 
with medium HDI. 
Our findings also showed that there was a direct, strong, 
and meaningful correlation between the standardized 
incidence rate and HDI (r=0.725, p≤0.001) (Figure1). 
Pearson correlation test showed that there was a significant 
correlation between ASIR and components of the HDI 
(life expectancy at birth, mean years of schooling, and 
GNP) (Table2). On the other, a week and non-significant 
relationship was observed between ASMR and HDI 
Map 1. Distribution of the Standardized Incidence 
Rate of Breast Cancer in World in 2012 (extracted 
from Globocan 2012)
	  
Map 2. Distribution of Standardized Breast Cancer 
Mortality Rates in World in 2012 (extracted from 
Globocan 2012)
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Table 1. MIR in the Six Regions of W.H.O
Regions ASR AMSR MIR
AFRO 34.5 17.2 0.5
PAHO 67.6 14 0.21
EMRO 41.9 18.6 0.44
EUROP 66.5 16 0.24
SEARO 27.8 12.9 0.46
WPRO 28.6 7 0.25
Table 2. The Incidence and Mortality from Breast 
Cancer by HDI
Regions                Morbidity               Mortality 
 Numbers ASR Numbers MSR
More developed 788200 73.4 197618 14.9
Less developed 882949 31.3 324289 11.5
Very High Human Development 747203 78.2 169131 14.1
High Human Development 281687 45.2 95646 14.6
Medium Human Development 493807 26.5 182166 9.8
Low Human Development 147415 32.6 74678 17
World 1671149 43.1 521907 12.9
Figure 1. Correlation between HDI and Standardized 
Incidence of Breast Cancer in World in 2012
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(r=0.091, p=0.241). In total, a significant relationship 
was not found between ASMR and components of HDI 
(Table3).
Discussion
Cancer is one of the most important health problems 
in the world (Stewart and Wild, 2014; Almasi et al., 
2015; Razi et al., 2015). Breast cancer is very common 
in women in developed and developing countries (Clegg 
et al., 2009). Developed countries in West Europe face 
96per 100,000for breast cancer. Although the incidence 
is lower in the less developed and developing countries, it 
will be increased, according to increasing life expectancy, 
increasing urbanization, and adoption of western lifestyle 
(WHO, 2015b). A study in India revealed that long-term 
living in the countryside and rural lifestyle reduces the 
risk of breast cancer (Nagrani et al., 2014). Prevention 
may somewhat reduce the risk of cancer, but this strategy 
cannot eliminate the majority of breast cancer in low 
and middle income countries, where breast cancer is 
diagnosed in very late stages. Therefore, early detection 
to improve the outcome of breast cancer treatment and 
survival is the cornerstone of breast cancer control. The5-
year survival of patients is very different in the world, 
so that it is more than 80 percent in North America and 
less than 40 percent in low-income countries (WHO, 
2015b). Socioeconomic status is directly correlated with 
disease stage and patient’s survival (Clegg et al., 2009). 
Studies showed that patients with higher socioeconomic 
conditions are diagnosed earlier, and with controlling for 
other risk factors experience greater survival (Kish et al., 
2014). Low survival of patients in developing countries 
is more related to the properties tumor, like the invasive 
tumor, and the lack of diagnostic and treatment facilities. 
As a result, the likelihood of developing more severe 
stages of the disease increases (Downing et al., 2007). 
The researchers suggest that in low-income countries 
women should be considered in terms of education Breast 
Self-Examination (BSE). Although this method does not 
reduce deaths due to breast cancer, it increases women’s 
awareness. Given the lack of resources in these countries, 
screening with mammography is questioned, and BSE 
can be continuously used (Albert and Schulz, 2003). 
Mammography in low and middle income countries is not 
more efficient and cost effective (Harford, 2011). 
Unfortunately, in countries with limited resources, 
healthcare professionals are more in developed areas such 
as big and the central cities. Inadequate income, lack of 
appropriate job, lack of infrastructure, and working and 
living conditions lead to inappropriate distribution of 
specialists. To reduce this problem, governments must 
have sufficient effort so that all women can have access 
to healthcare (Kantelhardt et al., 2008).
According to the report of W.H.O, countries such as 
Fiji, Bahamas, Nigeria, and Pakistan with the highest 
death rates from breast cancer have no population-based 
national cancer registry (WHO, 2014).
Bray et al. also found the positive correlation between 
HDI and the cancer. In their study, it is shown that with 
increasing development, the incidence of cancers such 
as skin cancer increases, but the cancer associated with 
infectious agents reduces (Bray et al., 2012). In a study on 
HDI and breast cancer in Asia, it was also shown that the 
incidence of cancer increases with increasing HDI, and 
a significant positive correlation was observed between 
HDI and the incidence of the cancer, but this was not 
significant related to the death (Ghoncheh et al., 2014). 
Amit R. Patel et al. studied the relationship between 
HDI and kidney cancer, and found that the incidence and 
mortality of kidney cancer is reduced by increasing the 
HDI (Patel et al., 2012). One of the components of HDI 
is access to knowledge. A significant positive correlation 
between the knowledge and behavior of people in care 
and screening has been seen in studies (Chen et al., 2014). 
Mothers with low education receive less health care, and 
less likely to seek health care .Studies have shown that 
with increasing awareness, they more seek diagnostic 
and treatment services (Chen et al., 2014). Therefore, a 
positive relationship between cancer incidence and level 
of education could be due to early diagnosis.
In conclusion, The incidence of breast cancer is 
higher in countries with greater HDI than countries with 
lower HDI, while the mortality rate is greater in low HDI 
countries. There was no relationship between the incidence 
and mortality from the cancer. In other words, with 
increasing the incidence rate of the cancer, mortality rate 
from the cancer does not increase. Education of women is 
suggested in all countries for early detection and treatment. 
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